Loading…

Multitarget-Directed Drug Design Strategy:  A Novel Molecule Designed To Block Epidermal Growth Factor Receptor (EGFR) and To Exert Proapoptotic Effects

The multifactorial mechanistic nature of cancer calls for the development of multifunctional therapeutic tools, i.e., single compounds able to interact with multiple altered pathogenetic pathways. Following this rationale, we designed compounds able to irreversibly block epidermal growth factor rece...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2006-11, Vol.49 (23), p.6642-6645
Main Authors: Antonello, Alessandra, Tarozzi, Andrea, Morroni, Fabiana, Cavalli, Andrea, Rosini, Michela, Hrelia, Patrizia, Bolognesi, Maria Laura, Melchiorre, Carlo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The multifactorial mechanistic nature of cancer calls for the development of multifunctional therapeutic tools, i.e., single compounds able to interact with multiple altered pathogenetic pathways. Following this rationale, we designed compounds able to irreversibly block epidermal growth factor receptor (EGFR), and to induce apoptosis in tumor cell lines. The novel molecules were synthesized by combining the structural features of the EGFR inhibitor PD153035 (1) and lipoic acid, which among other therapeutic effects triggers apoptosis in human cancer cells.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm0608762